Position in GSK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$238,406
+$45,076 QoQ
Shares Held
4,548
+29.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#664
of 1,032 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Glen Eagle Advisors, LLC holds $41,817,560 across 12 Drug Manufacturers - General names. GSK ranks #8 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
113,724 | $28,882,484 | |
| 2 | ABBV |
AbbVie Inc.
|
21,140 | $5,319,669 | |
| 3 | LLY |
ELI LILLY & Co
|
3,599 | $4,316,748 | |
| 4 | MRK |
Merck & Co., Inc.
|
8,886 | $1,141,851 | |
| 5 | PFE |
Pfizer Inc
|
30,849 | $742,843 | |
| 6 | AMGN |
Amgen Inc
|
1,750 | $633,710 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
4,641 | $267,414 | |
| 8 | GSK |
GSK plc
This page
|
4,548 | $238,406 |
All Filings in GSK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $238,406 | 4,548 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $193,330 | 3,503 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $175,759 | 3,584 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $123,567 | 2,863 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $112,396 | 2,927 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $119,202 | 3,077 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $89,318 | 2,641 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | $106,247 | 2,599 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $100,446 | 2,609 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $68,034 | 1,587 | Shares | Sole | 2024-07-03 | |
| 2023-12-31 | $55,812 | 1,506 | Shares | Sole | 2024-08-13 | |
| 2023-09-30 | $54,556 | 1,505 | Shares | Sole | 2024-08-13 | |
| 2023-06-30 | $53,602 | 1,504 | Shares | Sole | 2024-08-13 | |
| 2023-03-31 | $53,476 | 1,503 | Shares | Sole | 2024-08-13 | |
| 2022-12-31 | $50,531 | 1,438 | Shares | Sole | 2024-08-13 | |
| 2022-09-30 | $41,054 | 1,395 | Shares | Sole | 2024-08-13 | |
| 2022-06-30 | $87,181 | 2,042 | Shares | Sole | 2024-08-13 | |
| 2022-03-31 | $87,711 | 2,053 | Shares | Sole | 2024-08-13 | |
| 2021-12-31 | $88,755 | 2,052 | Shares | Sole | 2024-08-13 | |
| 2021-09-30 | $81,023 | 2,162 | Shares | Sole | 2024-08-13 | |
| 2021-06-30 | $84,359 | 2,160 | Shares | Sole | 2024-08-13 | |
| 2021-03-31 | $75,540 | 2,158 | Shares | Sole | 2024-08-13 | |
| 2020-12-31 | $77,817 | 2,156 | Shares | Sole | 2024-08-13 | |
| 2020-09-30 | $84,134 | 2,279 | Shares | Sole | 2024-08-13 | |
| 2020-06-30 | $91,135 | 2,278 | Shares | Sole | 2024-08-13 | |
| 2020-03-31 | $83,764 | 2,254 | Shares | Sole | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||